Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected

Journal of Developmental and Behavioral Pediatrics

Volumn 33, Issue 2, 2012, Pages 112-123

  Rice, Mabel L ^a   Buchanan, Ashley L ^b   Siberry, George K ^c   Malee, Kathleen M ^d   Zeldow, Bret ^b   Frederick, Toni ^e   Purswani, Murli U ^f   Hoffman, Howard J ^g   Sirois, Patricia A ^h   Smith, Renee ⁱ   Torre, Peter ^j   Allison, Susannah M ^k   Williams, Paige L ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f BRONX LEBANON HOSPITAL CENTER   (United States)

^g NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^h TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^j SAN DIEGO STATE UNIVERSITY   (United States)

^k NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

more..

Author keywords

antiretroviral therapy; language impairment; pediatric HIV infection

Indexed keywords

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; CHILD; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HISPANIC; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE DISABILITY; LANGUAGE TEST; MALE; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; VERTICAL TRANSMISSION;

ADOLESCENT; AFRICAN AMERICANS; CHILD; FEMALE; HISPANIC AMERICANS; HIV; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LANGUAGE DISORDERS; LANGUAGE TESTS; MALE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84857058559     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e318241ed23     Document Type: Article

References (38)

1. Blanchette N, Smith ML, King S, Fernandes-Penney A, Read S. Cognitive development in school-age children with vertically transmitted HIV infection. Dev Neuropsychol. 2002;21:223-241. (Pubitemid 34977150)
2. Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L. Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Dev Neuropsychol. 2006;30:633-657. (Pubitemid 44619821)
3. Brackis-Cott E, Kang E, Dolezal C, Abrams EJ, Mellins CA. The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS. 2009;23:415-421.
4. Brackis-Cott E, Kang E, Dolezal C, Abrams EJ, Mellins CA. Brief Report: language ability and school functioning of youth perinatally infected with HIV. J. Pediatr Health Care. 2009;23: 158-164.
5. Coplan J, Contello KA, Cunningham CK, et al. Early language development in children exposed to or infected with Human Immunodeficiency Virus. Pediatrics. 1998;102:e8.
6. Malee K, Williams P, Montepiedra G, et al. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol. 2009;34:164-175.
7. Smith R, Malee K, Leighty R, et al. Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics. 2006;117:851-862. (Pubitemid 46063229)
8. Wolters PL, Brouwers P, Civitello L, Moss HA. Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study. AIDS. 1997;11:1135-1144. (Pubitemid 27273611)
9. Hopkins KM. Emerging patterns of services and case finding for children with HIV infection. Ment Retard. 1989;27:219-222. (Pubitemid 19236212)
10. Raskino C, Pearson DA, Baker CJ, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics. 1999;104:e32.
11. Lindsey JC, Malee KM, Brouwers P, Hughes MD; PACTG 219C Study Team. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy. Pediatrics. 2007;119:e681-e693. (Pubitemid 46407543)
12. Jeremy RJ, Kim S, Nozyce M, et al. Neuropsychological functioning and viral load in stable antiretroviral therapyexperienced HIV-infected children. Pediatrics. 2005;115:380-387. (Pubitemid 43193822)
13. Tepper VJ, Farley JJ, Rothman MI, et al. Neurodevelopmental/ neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIVspecific protease inhibitor Ritonavir. Pediatrics. 1998;101:e7.
14. Chiriboga C, Fleishman S, Champion S, Gaye-Robinson L, Abrams E. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr. 2005;146:402-407. (Pubitemid 40347260)
15. Crain MJ, Chernoff MC, Oleske JM, et al. Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. J Infect Dis. 2010;202: 291-301.
16. Fischel-Ghodsian N. Mitochondrial deafness mutations reviewed. Hum Mutat. 1999;13:261-270. (Pubitemid 29307069)
17. Zhao H, Young W, Yan Q, et al. Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss. Nucleic Acids Res. 2005;33:1132-1139. (Pubitemid 41430533)
18. Tomblin JB, Records NL, Buckwalter P, Zhang X, Smith E, O'Brien M. The prevalence of specific language impairment in kindergarten children. J Speech Hear Res. 1997;40:1245-1260. (Pubitemid 28008821)
19. Shriberg LD, Tomblin JB, McSweeny JL. Prevalence of speech delay in 6-year-old children and comorbidity with language impairment. J Speech Lang Hear Res. 1999;42:1461-1481.
20. Rice ML, Tomblin JB, Hoffman L, Richman WA, Marquis J. Grammatical tense deficits in children with SLI and nonspecific language impairment: relationships with nonverbal IQ over time. J Speech Lang Hear Res. 2004;47:816-834. (Pubitemid 39129115)
21. Mashburn AJ, Myers SS. Advancing research on children with speech-language impairment: an introduction to the early childhood longitudinal study-kindergarten cohort. Lang Speech Hear Serv Sch. 2010;41:61-69.
22. Catts HW, Bridges MS, Little TD, Tomblin JB. Reading achievement growth in children with language impairments. J Speech Lang Hear Res. 2008;51:1569-1579.
23. Johnson C, Beitchman JH, Young A, et al. Fourteen-year followup of children with and without speech/language impairments: speech/language stability and outcomes. J Speech Lang Hear Res. 1999;42:744-760. (Pubitemid 29287950)
24. Nelson NW. Language and Literacy Disorders: Infancy Through Adolescence. Boston, MA: Allyn & Bacon; 2010.
25. Rice ML, Warren SF, Betz SK. Language symptoms of developmental language disorders: an overview of autism, Down syndrome, fragile X, specific language impairment, and Williams syndrome. Appl Psycholing. 2005;26:7-27. (Pubitemid 40145122)
26. Dollaghan CA, Campbell TF, Paradise JL, et al. Maternal education and measures of early speech and language. J Speech Lang Hear Res. 1999;42:1432-1443.
27. Semel E, Wiig EH, Secord WA. Clinical Evaluation of Language Fundamentals. 4th ed. San Antonio, TX: The Psychological Corporation; 2003.
28. Rice ML, Smith SD, Gayán J. Convergent genetic linkage and associations to language, speech and reading measures in families of probands with specific language impairment. J Neurodev Disord. 2009;1:264-282.
29. Wechsler D. Wechsler Intelligence Scale for Children. San Antonio, TX: the Psychological Corporation; 2003.
30. Entwisle DR, Astone NM. Some practical guidelines for measuring youths' race/ethnicity and socioeconomic status. Child Dev. 1994;65:1521-1540.
31. Zubrick SR, Taylor CL, Rice ML, Slegers D. Late language emergence at 24 months: an epidemiological study of prevalence, predictors, and covariates. J Speech Lang Hear Res. 2007;50:1562-1592. (Pubitemid 350211106)
32. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation; 1999.
33. Pena ED, Spaulding TJ, Plante E. The composition of normative groups and diagnostic decision making: shooting ourselves in the foot. Am J Speech Lang Pathol. 2006;15:247-254. (Pubitemid 44421927)
34. Falcaro M, Pickles A, Newbury DF, et al. Genetics and phenotypic effects of phonological short-term memory and grammatical morphology in specific language impairment. Genes Brain Behav. 2008;7:393-402. (Pubitemid 351590927)
35. Vernes SC, Newbury DF, Abrahams BS, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med. 2008;359:2337-2345.
36. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12:389-394. (Pubitemid 23150802)
37. Buckingham SC, McCullers JA, Lujan-Zilbermann J, Knapp KM, Orman KL, English BK. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis. Pediatrics. 2006;117:1688-1694. (Pubitemid 46071398)
38. Chase C, Ware J, Hittelman J, et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Pediatrics. 2000;106:e25.